Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
Sluiten
Over ons Praktische zaken Waar vindt u ons prof. dr. G.H. (Truuske) de Bock
University Medical Center Groningen

prof. dr. G.H. (Truuske) de Bock

Hoogleraar oncologische epidemiology
Research interests Publicaties Pers/media

Research interests

The research of Geertruida de Bock is about the early detection of cancer and improvement of outcomes after cancer treatment. To evaluate this in a systematic way, she set up an UMCG’s oncology databiobank OncoLifeS with quality of life as a main outcome. To assess and optimize screening strategies, she works on defining which populations are at risk of cancer and negative outcomes. She does not only consider benefits of screening and treatment, but also the negative effects of over-diagnosis, tumor-induction, false-positive results, and side-effects. Systematic literature reviews, analysis of cohorts and modelling are the most important methods she uses.

Publicaties

Artificial intelligence as an independent reader of risk-dominant lung nodules: influence of CT reconstruction parameters

Mao, Y., Heuvelmans, M. A., van Tuinen, M., Yu, D., Yi, J., Oudkerk, M., Ye, Z., de Bock, G. H. & Dorrius, M. D., mrt-2026, In: European Radiology. 36, blz. 2014 - 2023 10 blz.

Onderzoeksoutput › › peer review

Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysis

Suazo-Zepeda, E., Heuvelmans, M. A., Postmus, D., Hiltermann, T. N. J., Viddeleer, A. R. & de Bock, G. H., 28-feb-2026, In: Translational lung cancer research. 15, 2, 13 blz., 29.

Onderzoeksoutput › › peer review

Clinical validation of a three-marker methylation panel to detect CIN3+ in vaginal self-samples in the Dutch population-based screening programme

de Waard, J., Bhattacharya, A., de Boer, M. T., van Hemel, B. M., Esajas, M. D., Vermeulen, K. M., de Bock, G. H., Schuuring, E. & Wisman, G. B. A., 2026, In: Clinical Epigenetics. 18, 1, 11 blz., 97.

Onderzoeksoutput › › peer review

Corrigendum to "Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands" [Eur J Cancer 205 (2024)114125]

de Jager, V. D., Cajiao Garcia, B. N., Kuijpers, C. C. H. J., de Bock, G. H., Maas, W. J., Timens, W., van Kempen, L. C., van der Wekken, A. J., Schuuring, E. & Willems, S. M., 26-mrt-2026, In: European Journal of Cancer. 237, 1 blz., 116597.

Onderzoeksoutput: Erratum

FIGO 2021 depth of invasion measurement and missed lymph node involvement in microinvasive vulvar squamous cell carcinoma: Is the gain worth the cost?

van der Kolk, W. L., Landsbergen, K., van der Zee, A. G. J., de Bock, G. H., Oonk, M. H. M. & Bart, J., 15-mei-2026, In: European Journal of Cancer. 239, 5 blz., 116695.

Onderzoeksoutput › › peer review

Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016)

Lin, Y., Sidorenkov, G., Wang, J., Greuter, M. J. W., Houssami, N., Dorrius, M. D., Siesling, S., de Munck, L. & de Bock, G. H., apr-2026, In: The Breast. 86, 7 blz., 104745.

Onderzoeksoutput › › peer review

Improvement of Lung Nodule Volumetric Accuracy with Photon-counting Computed Tomography Over Energy-integrating Computed Tomography in Low-dose Screening: A Phantom Study

Hop, J. F., Greuter, M. J. W., van Dijk, M., de Bock, G. H. & Vliegenthart, R., 3-jun-2026, (E-pub ahead of print) In: Investigative radiology. 8 blz.

Onderzoeksoutput › › peer review

Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population

Zhong, D., Sidorenkov, G., Greuter, M. J. W., Jacobs, C., de Jong, P. A., Gietema, H. A., Groen, H. J. M., Mohamed Hoesein, F. A. A., Antonissen, N., Stadhouders, R., Lancaster, H. L., Heuvelmans, M. A., Vliegenthart, R. & de Bock, G. H., 24-feb-2026, In: Cancers. 18, 5, 14 blz., 724.

Onderzoeksoutput › › peer review

Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study

Poelhekken, K., Greuter, M. J. W., Dorrius, M. D. & de Bock, G. H., jan-2026, In: PLoS ONE. 21, 1, 10 blz., e0331821.

Onderzoeksoutput › › peer review

Integrated geriatric assessment and intervention in the head and neck oncology care pathway reduces adverse events and does not affect survival

Padovan, B. V., Beenker, M., Langendijk, J. A., van der Laan, H. P., van Dijk, B. A. C., de Bock, G. H., Plaat, B. E. C., de Graeff, P., Festen, S. & Halmos, G. B., jan-2026, In: Oral Oncology. 172, 7 blz., 107811.

Onderzoeksoutput › › peer review

Pers/media

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

de Bock, T.

20/11/2023

Pers / media: Expert Comment ›

Mannen krijgen vaker kankertherapie die de tumor aanpakt dan vrouwen

de Bock, G.

20/11/2023

Pers / media: Expert Comment ›

Steeds meer mensen met kanker

de Bock, T.

06/05/2022

Pers / media: Expert Comment ›

Steeds meer mensen met kanker: 'Zien nu effecten van veel roken en zonnen'

de Bock, T.

04/05/2022

Pers / media: Expert Comment ›

UMCG krijgt vier ton subsidie voor verbetering onderzoek naar baarmoederhalskanker.

Schuurs-Wisman, B., Schuuring, E. & Bock, de, T.

27/06/2019

Pers / media: Onderzoek ›

Bekijk volledig onderzoeksprofiel
Volg de RUG
Stel je cookievoorkeur in. Lees onze privacy en cookie disclaimer voor meer informatie.